| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DNA | Class A Common Stock | Options Exercise | +65,284 | +12% | 596,020 | 31 Mar 2023 | Direct | F1 | ||
| transaction | DNA | Class A Common Stock | Options Exercise | +18,125 | +3% | 614,145 | 31 Mar 2023 | Direct | F2 | ||
| transaction | DNA | Class A Common Stock | Sale | $49,221 | -38,787 | -6.3% | $1.27 | 575,358 | 03 Apr 2023 | Direct | F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DNA | Restricted Stock Units | Options Exercise | -65,284 | -4.2% | 1,496,325 | 31 Mar 2023 | Class A Common Stock | 65,284 | Direct | F1 | |||
| transaction | DNA | Restricted Stock Units | Options Exercise | -18,125 | -2.1% | 851,875 | 31 Mar 2023 | Class A Common Stock | 18,125 | Direct | F2, F4 |
| Id | Content |
|---|---|
| F1 | Represents restricted stock units (the "RSUs") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the "Merger"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition with respect to 65,284 of the RSUs was satisfied on April 1, 2023, and the Issuer elected to deliver one share of Class A Common Stock to the Reporting Person for each such RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock at the option of the Reporting Person. |
| F2 | Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| F3 | Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. |
| F4 | The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. |
Chief Financial Officer